摘要
目的探讨微生态制剂(培菲康)联合思密达治疗新生儿轮状病毒性肠炎的临床疗效。方法对90例新生儿轮状病毒性肠炎患儿随机分为3组,在液疗、纠酸等治疗基础上,A组加用培菲康治疗,B组加用思密达治疗,C组加用培菲康联合思密达治疗,比较三组临床疗效。结果A、B、C组的总有效率分别为63·33%、66·67%、93·33%,平均止泻时间分别为(75·21±3·28)h、(73·33±5·05)h、(57·51±5·72)h。无论总有效率或平均止泻时间,C组与A组或B组相比,差异均有显著性(P<0·05或<0·01)。结论微生态制剂(培菲康)联合思密达治疗新生儿轮状病毒性肠炎的疗效肯定,值得临床推广使用。
Objective To observe the effect of administration of semecta and microbial preparations for curing rotavirus enteritis in neonates.Methods A total of 90 case of rotavirus entertis in neonates were divided randomly into three groups.They were all treated with sythetical therapy in addition.A group were treated with Bifid Triple Viable Powder;B group were treated with semecta;C group were treated with Bifid Triple Viable Powderand semecta.Then the effect of tree groups were compared.Results The cured rate of three groups were 63.33%,66.67%,93.33%,the time of recovery were(75.21±3.28)h,(73.33±5.05)h,(57.51±5.72)h,respectively.There was a statistic difference(P<0.05or<0.01)in A group and C group or B group and C group.Conclusion Microbial preparations and semecta can markedly increase the cured rate,short the recovery time,and there has an important clinical significance.
出处
《中国实用医药》
2007年第8期55-56,共2页
China Practical Medicine
关键词
轮状病毒性肠炎
微生态制剂
培菲康
思密达
新生儿
Rotavirus enteritis
Microbial preparations
Bifid Triple Viable Powder
Semecta
Neonates